This site is intended for healthcare professionals only
LoginRegister
Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in ExpansionBiocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report
AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium CyclosilicateAstraZeneca Tagrisso plus chemotherapy approved in EU for EGFR-mutated advanced lung cancer
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3%Zydus Lifscience Gets CDSCO Panel Nod to Manufacture, Market Nivolumab for Metastatic Non-small Cell...
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalJnJ gets USFDA, European Commission nod for Sirturo
Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ BioAstraZeneca India to expand Chennai Global Innovation and Technology Centre with Rs 250 crore...
ChargePoint Technology unveils new subsidiary in IndiaChargePoint Technology unveils new subsidiary in India
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCAstraZeneca Pharma India gets CDSCO Panel Nod to study anti-cancer drug Datopotamab...
USFDA approves Caplin Steriles Milrinone Lactate in 5% Dextrose Injection, Infusion bagsRoche Vabysmo prefilled syringe bags USFDA nod for three causes of vision loss
PULSUS Group to establish AI based Pharma Healthcare IT Hub in TelanganaPULSUS Group to establish AI based Pharma Healthcare IT Hub in Telangana
CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan ScientificYogi Govt initiates development of Lalitpur Bulk Drug Pharma Park into pharma hub
One Death a Day: 1,705 Lives Lost in Indias Clinical Trials Since 2021, RTI RevealsShilpa Medicare CDMO customer reports positive results from Oxylanthanum Carbonate trial
Mounjaro, Wegovy sales in India double on month in JulyNovo Nordisk Gets CDSCO Panel Nod to Study Cagrilintide plus semaglutide
X